Position in NBIX
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$3,868,835
+$1,589,734 QoQ
Shares Held
22,955
+32.7% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#241
of 768 holders
Holding Since
Mar 2020
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Aberdeen Group plc holds $220,070,795 across 11 Drug Manufacturers - Specialty & Generic names. NBIX ranks #8 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
919,823 | $66,098,479 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
|
5,310,871 | $53,108,710 | |
| 3 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
403,485 | $25,802,865 | |
| 4 | ANIP |
Ani Pharmaceuticals Inc
|
271,760 | $22,496,292 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
|
453,206 | $21,078,610 | |
| 6 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
737,670 | $13,248,553 | |
| 7 | ALKS |
Alkermes plc.
|
193,805 | $10,154,412 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
This page
|
22,955 | $3,868,835 |
All Filings in NBIX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,868,835 | 22,955 | Shares | Defined | 2026-07-31 | |
| 2026-03-31 | $2,279,101 | 17,300 | Shares | Defined | 2026-04-29 | |
| 2025-12-31 | $5,675,468 | 40,016 | Shares | Defined | 2026-01-16 | |
| 2025-09-30 | $12,640,516 | 90,045 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $14,867,367 | 118,286 | Shares | Defined | 2025-07-24 | |
| 2025-03-31 | $24,370,046 | 220,344 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $21,372,351 | 156,574 | Shares | Defined | 2025-01-24 | |
| 2024-09-30 | $15,718,773 | 136,424 | Shares | Defined | 2024-10-25 | |
| 2024-06-30 | $22,185,106 | 161,147 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $11,476,598 | 83,212 | Shares | Defined | 2024-05-09 | |
| 2023-12-31 | $11,019,483 | 83,633 | Shares | Defined | 2024-01-31 | |
| 2023-09-30 | $361,462 | 3,213 | Shares | Defined | 2023-11-07 | |
| 2023-06-30 | $328,352 | 3,482 | Shares | Defined | 2024-06-20 | |
| 2023-03-31 | $200,213 | 1,978 | Shares | Defined | 2024-06-20 | |
| 2021-03-31 | $332,497 | 3,419 | Shares | Defined | 2021-05-06 | |
| 2020-12-31 | $303,269 | 3,164 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $270,978 | 2,818 | Shares | Defined | 2020-10-21 | |
| 2020-06-30 | $622,322 | 5,101 | Shares | Defined | 2020-08-10 | |
| 2020-03-31 | $7,059,190 | 81,562 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||